854 results on '"Masuzaki, Hideaki"'
Search Results
2. Comprehensive immune complexome analysis detects disease-specific immune complex antigens in seminal plasma and follicular fluids derived from infertile men and women
3. Natural Course of Human T-Cell Leukemia Virus Type 1 Proviral DNA Levels in Carriers During Pregnancy
4. Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy
5. Management of Ovarian Cancer in the Elderly Population
6. Prevention of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Mother-to-Child Transmission
7. Weekend and off-hour effects on the incidence of cerebral palsy: contribution of consolidated perinatal care
8. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan
9. Biological differences between functionalis and basalis endometria in women with and without adenomyosis
10. Molecular detection of intrauterine microbial colonization in women with endometriosis
11. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
12. Supplementary Table 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
13. Supplementary Table 5 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
14. Supplementary Table 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
15. Supplementary Table 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
16. Supplementary Figure 8 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
17. Supplementary Table 1 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
18. Supplementary Figure 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
19. Supplementary Figure 7 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
20. Supplementary Table 4 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
21. Supplementary Figure 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
22. Supplementary Figure 4 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
23. Supplementary Figure 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
24. Supplementary Figure 5 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
25. Supplementary Materials and Methods from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
26. Supplementary Figure 1 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
27. Pregnancy-associated microRNAs in plasma as potential molecular markers of ectopic pregnancy
28. Decreased expression of human heat shock protein 70 in the endometria and pathological lesions of women with adenomyosis and uterine myoma after GnRH agonist therapy
29. Fetiform teratoma was a parthenogenetic tumor arising from a mature ovum
30. Ovarian Reserve in Patients with Endometriosis
31. Visible and occult microscopic lesions of endometriosis
32. Effect of GnRH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis
33. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas
34. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma
35. Circulating Levels of Pregnancy-Associated, Placenta-Specific microRNAs in Pregnant Women With Placental Abruption
36. Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in Japan
37. A significant association between rs8067378 at 17q12 and invasive cervical cancer originally identified by a genome-wide association study in Han Chinese is replicated in a Japanese population
38. Increased Levels of Cell-Free miR-517a and Decreased Levels of Cell-Free miR-518b in Maternal Plasma Samples From Placenta Previa Pregnancies at 32 Weeks of Gestation
39. 17β-Estradiol and Lipopolysaccharide Additively Promote Pelvic Inflammation and Growth of Endometriosis
40. 長崎大学医学部
41. Three-dimensional saline-infusion sonohysterography is useful for the identification of endometrial polyp
42. Survey of prenatal testing for genetic disorders in Japan: Recent report
43. Adult T-cell leukemia–lymphoma in a pregnant woman diagnosed as a human T-cell lymphotropic virus type 1 carrier
44. Effect of human seminal fluid on the growth of endometrial cells of women with endometriosis
45. Correction: Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in Japan
46. Authorsʼ reply re: Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series
47. Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia
48. Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology
49. National survey of fibrinogen concentrate usage for post-partum hemorrhage in Japan: Investigated by the Perinatology Committee, Japan Society of Obstetrics and Gynecology
50. Circulating levels of maternal plasma cell-free miR-21 are associated with maternal body mass index and neonatal birth weight
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.